Log In
BCIQ
Print this Print this
 

INT0031

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionOral controlled-release film based on IntelGenx's VersaFilm technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today